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Abstract: We examined the role of ultraviolet radiation (UVR) in persons diagnosed with 
multiple sclerosis (MS) in four different populations, Italians, Danish, White and African 
Americans. We tested whether variation in UVR as determined by seasons (short term 
variation) and solar cycles (long term variation) is related to MS birth month and to 
survival as measured by lifespan. Cases were selected from three Italian MS Case 
Registries (2,737); from the United States National Center for Health Statistics (56,020); 
and from the Danish Multiple Sclerosis registry (15,900). Chi-square tests were used to 
study the pattern of month of birth distribution in patients with MS comparing with general 
population data. T-tests were employed to study solar cycles association with lifespan. A 
surplus of births was observed in June for White Americans. A decrease of births in 
October and November, though not significant after multiple testing correction, was 
observed in the three populations. In White American with MS overall, males and females, 
we found that solar cycle is associated with lifespan. We found that season and solar cycles 
have some role in MS susceptibility and life duration. However, this is an exploratory 
analysis and further work is needed to discern the association. 
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1. Introduction 
Solar radiation not only supplies the biosphere with energy and synchronizes circadian rhythms, but 
may also actively modify genomes, both through mutation and epigenetic mechanisms [1]. Many 
epidemiological studies report that some diseases occur with higher incidence in persons born in 
particular months, referred to as seasonality [2]. This suggests that an environmental factor may 
operate during gestation. Seasonal pattern of birth have been observed for schizophrenia and bipolar 
disorders [3], and for some autoimmune diseases, as type 1 diabetes [4], Crohn’s disease [5],   
myositis [6] and celiac disease [7] among others.  
Seasonality effects have also been found for multiple sclerosis (MS) [8], a chronic inflammatory 
autoimmune disease of the central nervous system, which causes myelin destruction and neuronal cell 
degeneration leading the patient to a progressive disability. The disease has a higher incidence in 
females than in males and most commonly presents in the second to fourth decade of life. The cause of 
MS is unknown, but it most likely results from a complex interplay of both genetics and environmental 
factors. While genetic factors shape the overall population susceptibility, epidemiological studies 
suggest an important role of the environment in disease initiation and modulation [9]. Findings on 
seasonality effects, however, are not consistent. A Canadian study using data from Canada and UK and 
combined with previously reported data from Denmark and Sweden [8] found a statistically significant 
difference in seasonal pattern of births among MS patients, but to estimate the numbers of MS cases 
born in a particular month, the authors summed number of births over the years 1926–1970 without 
taking into account year of birth. It has been argued [10] that biases could have arisen as MS cases 
born in one year were weighted relative to persons with completely different follow-up time. Another 
Canadian study [11] was unable to detect any significant seasonal difference. In Sicily, an excess in Int. J. Environ. Res. Public Health 2012, 9  687 
 
 
birth of MS patients occurred in the summer, with a peak in August [12]. A trend was also seen in a 
recent study on 1524 Australian patients with excess risk for those born in November-December, 
which is equivalent to April–May in the Northern hemisphere [13]. 
A relationship between the geographical distribution of MS, exposure to sunlight, and 
hypovitaminosis D has long been advocated [14]. Scientists have hypothesized that MS is rare in the 
tropics because people synthesize great quantities of vitamin D from exposure to ultraviolet   
radiation (UVR) in equatorial sunlight. On the contrary, MS is more prevalent in the high latitudes of 
Northern Europe and America where there is less exposure to sunlight [15]. Sardinia is an exception to 
this rule possibly due to inbreeding and genetic drift. Indeed, it has a high UVR exposure and a high 
MS prevalence comparable to that of Northern Europe [16]. These arguments support the so called 
“latitude hypothesis”, i.e., vitamin D may protect against the development of MS [17]. Prevalence of 
MS is lower than expected at high latitude where vitamin D intake is high because of fatty fish 
consumption [18]. Also, MS seems to decrease with migration from an higher to a lower latitude [19]. 
However, as emphasized by two recent reviews, a direct cause-and-effect relationship between vitamin 
D deficiency and MS has not yet been established thus suggesting that UVR may have effects beyond 
making vitamin D [18,20,21]. 
Davis and Lowell reported the association between intensity of solar radiation, referred as solar 
cycles, and various diseases [22]. The term “solar cycle” refers to the periodic rise and fall of the 
intensity of solar radiation where the Sun increases its irradiance on average every 11 years (range 9–14). 
Sunspots, the manifestation of magnetic storms on the Sun’s surface, are proxies for increase radiation 
intensity and have been recorded for centuries. During cycle peaks, sunspots increase in number and 
size with a concomitant increase in radiation [23]. In particular, the solar cycle variation causes as 
much as a 400% variation in UVB at 300 nm reaching the earth [24]. Relatively small changes in solar 
radiation (0.1%), due to solar cycle variability, may also significantly modify regional surface 
temperatures [25]. 
These results and those regarding seasonality, support the notion that UVR is instrumental in 
modifying the human genome not only by overt mutation DNA, but also by an epigenetic mechanism [1]. 
This hypothesis is supported by the recent work of Feng et al. showing that binding of histone 
deacetylase 3 (HDAC3) to the genome depends on light circadian rhythm: thus light can actually 
contribute to chromatin remodeling, modifying gene expression [26]. UVR significantly affects DNA 
and the effects are cumulative throughout life [27]. Epigenetic mechanisms are important as they 
enable the embryo to quickly modify its genetic library to match current environmental conditions and 
hence to maximize survival. Human lifespan may be modulated by sunlight as there is a statistically 
significant variation in lifespan by month of birth between peaks and non-peaks of solar cycles [23]. 
The aim of this study is to examine the role of UVR in persons diagnosed with MS in four different 
populations, Italians, Danish, and White and African Americans. In particular we test whether 
variation in UVR as determined by seasons (short term variation) and solar cycles (long term variation) 
is related to MS birth month and to survival as measured by lifespan. 
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2. Experimental Section  
2.1. Study Populations 
Italy: Demographical data of MS patients were collected from the Case Registry of the Division of 
Neurology of the Nuoro Hospital, Sardinia (n = 890); from the Case Registry of the Interdepartment 
Research Center for Multiple Sclerosis, Neurological Institute Casimiro Mondino, Pavia (n = 683); and 
from the Case series from San Raffaele Scientific Institute (ISR), Milan (n = 1164). The three 
registries are ongoing. They were started respectively in 1995, 1990 and 1996. 
For this study, all records include birth year (YOB), birth month (MOB) and gender. National and 
regional data of month/year specific birth were retrieved from the Italian Statistical Institute (ISTAT) 
database. We normalized for the Italian general population data as the MOB distribution in the three 
studied Italian areas did not differ significantly. All Italian patients were of Caucasian origins. 
USA: Death records were collected from the United States National Center for Health Statistics 
(NCHS) from 1979 to 2005 which contains 59 million death records. ICD9 code 340 and ICD10 code 
G35 for cause of death were used to extract records for MS (N = 56,020) from the NCHS data set. 
Data used in this sample included sex, ICD9 & ICD10 cause of death, state of birth, month and year of 
birth, month and year of death and ethnicity. National month/year specific birth was calculated using 
the NCHS dataset and pulling out the MS cases. As U.S. cases presented a great ethnic   
diversity (White, African American, American Indian, Asian and others), the analysis was restricted to 
the two largest ethnic groups: White and African Americans. White and African Americans were 
analyzed separately throughout because they respond differently to solar UVR. African American 
people have a different skin pigmentation and they more efficiently block UVB. As a consequence, 
they tend to be more vitamin D deficient. This unexpectedly inversely correlates with MS risk [18].  
Denmark: Cases were selected out of 15,900 cases from the Danish Multiple Sclerosis registry [28]. 
The registry was established in 1948 with a nationwide prevalence survey and has since then collected 
information on MS patients from multiple sources. Virtually all Danish residents in whom multiple 
sclerosis was diagnosed by a neurologist or in a department of neurology are registered [29]. The 
registry is continuously updated with new information on registered cases and new cases. For the 
seasonality analysis, cases were selected to have a definite diagnosis of MS before 2005; while for the 
solar cycle analysis, deceased MS patients were chosen. National month/year specific birth were 
extracted from Statistics Denmark [30]. Almost all Danish cases were of Caucasian origin [31]. 
2.2. Solar Data 
The average number of annual sunspots per year was collected from the U.S. Department of 
Commerce National Oceanic and Atmospheric Administration (NOAA) web site [32] and the three 
peak years of sunspots of each of the past twelve cycles was obtained. Solar cycles MAX years are 
1905, 1906, 1907, 1917, 1918, 1919, 1927, 1928, 1929, 1937, 1938, 1939, 1947, 1948, 1949, 1957, 
1958, 1959, 1968, 1969, 1970, 1979, 1980, 1981, 1989, 1990, 1991, 2000, 2001, 2002. Solar cycles 
MIN years are 1895–1904, 1908–1916, 1920–1926, 1930–1936, 1940–1946, 1950–1956, 1960–1967, 
1971–1978, 1982–1988, 1992–1999, 2003–2005. Int. J. Environ. Res. Public Health 2012, 9  689 
 
 
2.3. Seasonality Analysis 
For the seasonality analysis, our hypothesis was that people with MS might show a different pattern 
of month of birth. For Italy and Denmark, expected cases were calculated based on the MOB of each 
general population born in the same years as the cases. The U.S. population based controls came from 
the 59 million death records and include all non-MS cases. Expected values for White and African 
Americans were calculated differently based on the birth distribution of White and African Americans 
in the general population. Chi-square statistics were calculated in 2 × 2 tables with the MOB in 
question against the remaining 11 months. We accounted for multiple testing using Bonferroni 
correction. 
2.4. Solar Cycles Analysis 
Age at death was calculated from month and year of birth to month and year of death. To examine 
the influence of solar cycles on survival, birth year data were grouped by solar maximum or solar 
minimum defined as follows: the year before and the year after the peak were defined as the Maximum 
Solar Period (MAX); the years before and after each three year MAX cycle were grouped as Minimum 
Solar Period (MIN). T-tests were use to determine whether the difference between MAX and MIN 
groups was due to chance variation. 
3. Results and Discussion  
The gender distribution of the MS study populations is reported in Table 1. The female:male ratio 
varies in the different populations with the Italians having the highest (the number of females with MS 
is more than twice the number of males) and the Danish the lowest (the number of females with MS is 
a bit more than one and a half the number of males). However, as expected, the number of affected 
females always exceeds the number of affected males. 
Table 1. Gender distribution of the MS study populations, n (%). 
Sex Italians  Danish White  Americans  African Americans
F  1,897 (69)  9,856 (62)  32,456 (64)  3,630 (67) 
M  840 (31)  6,044 (38)  18,194 (36)  1,740 (32) 
F:M  2.26 1.63  1.78  2.09 
TOTAL  2,737 15,900  50,650  5,370 
3.1. Seasonality Analysis 
We compared the number of individuals with MS born in each month versus the other 11 months. 
The expected number of births was calculated using the distribution of birth in the general population 
for Italy and Denmark (Table 2), and of population controls for the U.S. data (Table 3). 
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Table 2. Seasonality overall results for Italy and Denmark normalized for the specific general population data. 
  Italy Denmark 
MOB Obs  Exp  Obs/Exp  Month 
specific χ
2
p value  Obs  Exp  Obs/Exp  Month 
specific χ
2
p value 
(95% CI)  (95% CI) 
January  248  231  1.07[0.94; 1.21]  1.31  0.2531  1274  1304  0.98 [0.92;1.03]  0.75  0.3864 
February 204  204  1.00[0.86;  1.14]  0  0.9907  1240  1274  0.97[0.92;1.03]  0.99  0.3197 
March 241  219  1.10[0.96;  1.24]  2.49  0.1147  1523  1462  1.04[0.99;1.09]  2.8  0.0942 
April  238  203  1.17 [1.02; 1.32]  6.36  0.0117  1478 1420  1.04[0.99;1.09]  2.6 0.1068 
May  228  234 0.97[0.85;  1.1] 0.17  0.684  1451  1417  1.02[0.97;1.08] 0.9  0.3427 
June 242  221  1.10[0.96;  1.23]  2.2  0.1377  1384  1326  1.04[0.99;1.1]  2.77  0.0960 
July 220  240  0.92[0.8;  1.04]  1.75  0.1863  1322  1339  0.99[0.93;1.04]  0.24  0.6242 
August 216  235  0.92[0.79;  1.04]  1.76  0.1845  1358  1328  1.02[0.97;1.08]  0.74  0.3896 
September 243 251  0.97[0.85;  1.09]  0.26  0.6135  1263  1310  0.96[0.91;1.02]  1.84  0.1749 
October  219 250  0.88[0.76;  0.99]  4.15  0.0416  1243 1267  0.98[0.93;1.04]  0.49  0.4839 
November  208 224  0.93[0.80;  1.06]  1.22  0.27  1139  1208  0.94[0.89;1]  4.27  0.0389 
December 230 226  1.02[0.89;  1.15]  0.08  0.77251  1225  1246  0.98[0.93;1.04]  0.38  0.5376 
  chisq(11) = 19.95, p =0 .0461  chisq(11) = 17.19, p =0.1023 Int. J. Environ. Res. Public Health 2012, 9  691 
 
 
Table 3. Seasonality overall results for U.S. data normalized for the population based controls. 
  White Americans  African Americans 
MOB Obs  Exp  Obs/Exp 
(95% CI) 
Month 
specific χ
2
p value  Obs  Exp  Obs/Exp 
(95% CI) 
Month 
specific χ
2
p value 
January 4178 4291  0.97[0.94;1] 3.251  0.07137  458 452  1.01[0.92;1.1]  0.087 0.7681 
February 3894  4034  0.97[0.94;1]  5.279  0.021582 403 431  0.94[0.85;1.03]  1.978 0.1596 
March 4405  4402  1[0.97;1.03]  0.002  0.962259 460  480  0.96[0.87;1.05]  0.915  0.33876 
April 4033  4069  0.99[0.96;1.02]  0.346  0.556199 423  441  0.96[0.87;1.05]  0.8  0.37097 
May 4152  4140  1[0.97;1.03]  0.038  0.845688 411  443  0.93[0.84;1.02]  2.519  0.1125 
June 4255  4027  1.06[1.03;1.09]  14.024  0.000181 425 424  1[0.9;1.1]  0.003 0.9596 
July 4480  4318  1.04[1.01;1.07]  6.644  0.009948 504 453  1.11[1.01;1.21]  6.271 0.0123 
August 4537  4480  1.01[0.98;1.04]  0.796  0.372414 494 481  1.03[0.94;1.12]  0.386  0.5345 
September 4425 4416 1[0.97;1.03] 0.016  0.8997  463  464  1[0.91;1.09] 0.002  0.96 
October 4175 4312 0.97[0.94;1] 4.758  0.0291  483 441  1.1[1;1.2]  4.358 0.037 
November 4030 4016 1[0.97;1.03] 0.053  0.8179  394  407  0.97[0.87;1.07]  0.449 0.5027 
December 4086  4145 0.99[0.96;1.02]  0.915  0.33888  452  454  1[0.91;1.09]  0.01  0.92 
  chisq(11) = 33.16, p < 0.0001  chisq(11) = 16.30, p = 0.1304 Int. J. Environ. Res. Public Health 2012, 9  692 
 
In the Italian population (Table 2) we found a significant surplus of births in April (χ
 = 6.36, 
uncorrected p = 0.0117) and a lower incidence in October (χ
 = 4.15, uncorrected p = 0.0416)   
(Table 2), but these were not significant after multiple testing correction. When we analyzed males and 
females separately normalizing for males and females general population data, we found an excess of 
birth in April for Italian men (χ
 = 5.64, uncorrected p = 0.0175) and a decrease of birth in October for 
Italian women (χ
 = 5.02, uncorrected p = 0.025). However, these were not significant after multiple 
testing correction. 
In the Danish sample, a lower incidence was observed among people born in November (χ
 = 4.27, 
uncorrected p = 0.0389), but again this did not pass multiple testing correction (Table 2). We could not 
perform the analysis by sex as gender of the general population, according to MOB, was not available 
on the Statistic Denmark database. 
In the U.S. population, June and July had significantly more cases than expected for White 
Americans (June: 5.7% more, χ
 = 14.024, uncorrected p = 0.000181 or p = 0.002172 with Bonferroni 
correction; July: χ
 = 6.644, uncorrected p = 0.0099), while October had significantly less (χ
 = 4.758, 
uncorrected p = 0.0291). Only June was significant also after accounting for multiple testing using 
Bonferroni correction (Table 3). A surplus of birth in July was also seen in African Americans   
(χ
 = 6.271, uncorrected p = 0.0123), though not significant after multiple testing correction and an 
excess of birth was observed in October (χ
 = 4.358, uncorrected p = 0.037).  
When stratifying by sex, we confirmed a statistical significant increase in births in June and July for 
White American females (June: 6.2%, χ
 = 10.58, uncorrected p = 0.001146 or p = 0.013752 with 
Bonferroni correction; July: χ
 = 4.89, uncorrected p = 0.027059), and a significant increase in births in 
May for white American males (χ
 = 4.39, uncorrected p = 0.0361) and a decrease of birth in October 
for white American males (χ
 = 4.3, uncorrected p = 0.0382). Again, June only was significant after 
accounting for multiple testing correction. A surplus of birth was also observed in African American 
females (χ
 = 6.02, uncorrected p = 0.014168), while no difference was found in African American men. 
3.2. Solar Cycles Analysis 
From the NOOA database, the average annual sunspot number for the past 250 years is 49; for the 
past 60 years the average is 107.5; for the most powerful cycles (sunspots >135), the average is 154, 
about three times the 250-year average. Also, the average annual sunspot number in a MAX year is 
107.71 (SD = 43.33), while the average annual sunspot number in a MIN year is 38.73 (SD = 33.60). It 
was not possible to perform a solar cycle analysis on the Italian cohorts as the majority of the   
patients (>99%) were still alive. 
We found a statistically significant association in White Americans (Table 4): those born in solar 
cycles MAX years have a significantly shorter lifespan (−0.64 year, p ≤ 0.0001) than those born in 
solar cycles MIN years. When we stratified by sex (Table 5), we saw similar results for both White 
American males (−0.5 year, p  = 0.0184) and females (−0.71 year, p  = 0.0006). No significant 
difference emerged neither in the African American sample nor in the Danish population. 
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Table 4. Counts and Mean age at death by solar Max and solar MIN for the MS cohort data. 
  White Americans  African Americans  Danish 
RGRP  N  Mean (SD)  N  Mean (SD)  N  Mean (SD) 
MAX  15,054  59.43 (13.26)  1,591  51.68 (13.26)  1,974  60.09 (13.60) 
MIN  35,596  60.07 (13.67)  3,779  51.57 (13.75)  5,195  60.26 (13.76) 
    p ≤ 0.0001    p = 0.7849    p = 0.6517 
Table 5. Mean age at death for the MS cohort by sex. 
  Males Females 
 
White 
Americans 
Black 
Americans 
Danish 
White 
Americans 
Black 
Americans 
Danish 
RGRP  N  Mean 
(SD) 
N  Mean 
(SD) 
N  Mean 
(SD) 
N  Mean 
(SD) 
N  Mean 
(SD) 
N  Mean 
(SD) 
MAX  5,440 58.82 
(12.74) 
521 51.45 
(13.22) 
889 59.25 
(13.09)
9,614 59.77 
(13.53)
1,070 51.79 
(13.28) 
1,085 60.78 
(13.41)
MIN  12,754 59.32 
(13.35) 
1,219 51.36 
(13.86) 
2,337 59.30 
(12.94)
22,842 60.48 
(13.83)
2,560 51.67 
(13.70) 
2,858 61.04 
(13.72)
  p = 0.0184  p = 0.9009  p = 0.9340  p < 0.0001  p = 0.7991  p = 0.6025 
3.3. Discussion 
In this paper, we first show that there is a significant pattern of risk of MS with MOB. Among 
White Americans with MS, 5.7% more than expected were born in June. This finding is confirmed in 
White American females where the percentage increases to 6.2%. A similar trend, though not 
significant after accounting for multiple testing, was found in White American men with a peak in 
May, for Italians with a peak in April and for Italian men with a peak again in April. A trend of lower 
risk of developing MS was observed in those born in October (White Americans: overall and males; 
Italians: overall and females) and in November (Danish). MOB October through November versus 
May through July mirrors months of conception January through February and August through 
October suggesting that increasing and decreasing UVR at conception has an effect on MS. This was 
also reported in a recent Australian study [13] where low maternal exposure to UVR at conception was 
associated with a higher risk of MS for the offspring. Moreover, an increase of births in April was seen 
in a French study [33], even though it did not reach statistical significance and in a pooled analysis of 
data from Canada, UK, Denmark and Sweden an excess of birth was reported in May and a decrease in 
November [8].  
In the U.S. sample, we found that there is a statistically significant difference between MAX and 
MIN solar cycle years for White Americans (overall, males and females). We were unable, however, to 
replicate this finding both on African Americans and in the Danish sample (Table 4). The reason for 
this could be that the difference in lifespan between those born in solar cycles MAX and MIN year is 
relatively small and hence it only reached the statistical significance in the U.S. sample, as it is a  
large cohort.  
A recent paper [34] about the MS genome in identical twins underscores that genetics alone do not 
explain the phenotype of MS; rather, an important environmental factor must be in play. We think that Int. J. Environ. Res. Public Health 2012, 9  694 
 
 
it may be UVR itself, possibly the ultraviolet range, in those that inherit a particularly sensitive   
sex-linked genome where females are twice as likely as males to develop MS (as confirmed in   
Table 1) because of their increased sensitivity to long-term changes in sunlight (Table 5). Increased 
sensitiveness of females to solar cycles could be explained considering the role of sunlight in   
vitamin D metabolism and the link between vitamin D and estrogen metabolism. Indeed, calcitriol, a 
biologically active compound derived from vitamin D, regulates the expression of the Cyp19, an 
aromatase necessary to synthesize estrogens [35–37]. Thus sunlight-driven variations in vitamin D 
level could also influence estrogen levels. 
Our study has some strengths. First, the Danish sample originates from a close to complete registry 
of a whole country with registration of cases in the last 60 years. Second, the U.S. sample is drawn 
from the NCHS, which contains more than 99% of all births and deaths registered in the U.S. Third, 
we had data on four different populations and hence the chance of comparing the effect of sunlight on 
people with different geographical and ethnic background. Moreover, previous studies of autoimmune 
diseases including celiac disease and myositis, show that birth season differs based on race or ethnicity 
[6,7]. We had information of ethnic background and were therefore able to run a stratified analysis.  
Our study also has some limitations. First, as the U.S. data is drawn from the NCHS and as there are 
more people dying with MS rather than of MS, we may have missed some cases. Indeed, a Danish 
study found that more than half (56.5%) MS patients have MS as cause of death on the death 
certificate [38]. It is likely that those excluded were patients suffering from a less severe MS (i.e., not 
severe enough to die from it). Second, we could not run the solar cycle analysis on the Italian data as 
the majority of the Italian patients were still alive. Third, the statistical analysis employed in the paper 
does not adjust for factors such as variation in viral outbreaks, epidemics, other seasonally varying 
factors such as ambient temperature, changes in diet, temporal trends, etc. and thus does not rule out 
the possibility that such factors might explain variation in season of birth or in lifespan based on year 
of birth. Also, it is impossible to untangle whether the observed surplus of births in June and July in 
the U.S. data, is due to the fact that MS is more likely to occur in those born in those months or if there 
is something about being born in those months that increases the risk of death.  
Finally, we recognize that we compared three different datasets with different methods of collecting data 
and that there are large methodological problems in doing so. However, this is an exploratory analysis.  
4. Conclusions 
We think that our results are novel and interesting. To our knowledge, we are the first to investigate 
long term UVR variation, measured as the influence of solar cycles, on MS. Even if the results are not 
replicated in all the population studied, we did find a significant signal in White American males and 
females and we believe this is worth reporting. Moreover, we confirm that there is a seasonality effect 
on MS suggesting that there is some environmental factor operating during gestation. 
The next steps would be to investigate (i) whether the difference in lifespan we observe for MS 
patients differs from other causes of death in magnitude; and (ii) whether people born in solar cycles 
MAX years differ for some genomic features from those born in solar MIN year. Assuming that solar 
radiation affects the human genome through mutation and epigenetic mechanisms, a case-only genome 
wide study of genetic and methylation profiles, comparing groups of MAX and MIN MS patients, Int. J. Environ. Res. Public Health 2012, 9  695 
 
 
could identify MS epigenetic susceptibility factors induced by exposure to solar radiation and genetic 
profiles ideally referable to vitamin D metabolism pathways. 
Acknowledgments 
We thank Giancarlo Comi, Maria Luisa Piras, Marzia Romeo, Valeria Saddi and Anna Ticca for 
patient enrolment. We thank Roberta Pastorino for her comments and suggestions. We thank Ari 
Minino at the NCHS for his contribution to the NCHS data sets. 
Conflict of Interest 
The authors declare no conflict of interest. The Danish MS registry is financed by the Danish   
MS society. The publication of this paper is funded by FISM grant number 2009-R-2. 
References 
1.  Davis, G.E.; Lowell, W.E. Peaks of solar cycles affect the gender ratio. Med. Hypotheses 2008, 
71, 829–838. 
2.  Tochigi, M.; Okazaki, Y.; Kato, N.; Sasaki, T. What causes seasonality of birth in schizophrenia? 
Neurosci. Res. 2004, 48, 1–11. 
3.  Torrey, E.F.; Rawlings, R.R.; Ennis, J.M.; Merrill, D.D.; Flores, D.S. Birth seasonality in bipolar 
disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophr. Res. 1996, 21, 141–149. 
4.  Vaiserman, A.M.; Carstensen, B.; Voitenko, V.P.; Tronko, M.D.; Kravchenko, V.I.;   
Khalangot, M.D.; Mechova, L.V. Seasonality of birth in children and young adults (0-29 years) 
with type 1 diabetes in Ukraine. Diabetologia 2007, 50, 32–35. 
5.  Van, R.M.; Joossens, M.; Joossens, S.; Van, S.K.; Pierik, M.; Vermeire, S.; Rutgeerts, P.   
Crohn’s disease and month of birth. Inflamm. Bowel. Dis. 2005, 11, 597–599. 
6.  Vegosen, L.J.; Weinberg, C.R.; O’Hanlon, T.P.; Targoff, I.N.; Miller, F.W.; Rider, L.G.   
Seasonal birth patterns in myositis subgroups suggest an etiologic role of early environmental 
exposures. Arthritis Rheum. 2007, 56, 2719–2728. 
7.  Lewy, H.; Meirson, H.; Laron, Z. Seasonality of birth month of children with celiac disease 
differs from that in the general population and between sexes and is linked to family history and 
environmental factors. J. Pediatr. Gastroenterol. Nutr. 2009, 48, 181–185. 
8.  Willer, C.J.; Dyment, D.A.; Sadovnick, A.D.; Rothwell, P.M.; Murray, T.J.; Ebers, G.C.   
Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005, 330, 120. 
9.  Pugliatti, M.; Harbo, H.F.; Holmoy, T.; Kampman, M.T.; Myhr, K.M.; Riise, T.; Wolfson, C. 
Environmental risk factors in multiple sclerosis. Acta Neurol. Scand. Suppl. 2008, 188, 34–40. 
10.   Hansen, T.; Meulengracht Flachs, E.; Stenager, E.; Koch-Henriksen, N. Response to Timing of 
birth and Multiple sclerosis. BMJ 2005. 
11.   Sadovnick, A.D.; Yee, I.M. Season of birth in multiple sclerosis. Acta Neurol. Scand. 1994, 89, 
190–191. 
12.   Salemi, G.; Ragonese, P.; Aridon, P.; Reggio, A.; Nicoletti, A.; Buffa, D.; Conte, S.; Savettieri, G. 
Is season of birth associated with multiple sclerosis? Acta Neurol. Scand. 2000, 101, 381–383. Int. J. Environ. Res. Public Health 2012, 9  696 
 
 
13.   Staples, J.A.; Ponsonby, A.L.; Lim, L.L. Low maternal exposure to ultraviolet radiation in 
pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.   
BMJ 2010, 340, c1640. 
14.   Schapira, K. The seasonal incidence of onset and exacerbations in multiple sclerosis.   
J. Neurol. Neurosurg. Psychiatry 1959, 22, 285–286. 
15.   Ascherio, A.; Munger, K. Epidemiology of multiple sclerosis: from risk factors to prevention. 
Semin. Neurol. 2008, 28, 17–28. 
16.   Pugliatti, M.; Rosati, G.; Carton, H.; Riise, T.; Drulovic, J.; Vecsei, L.; Milanov, I.   
The epidemiology of multiple sclerosis in Europe. Eur. J. Neurol. 2006, 13, 700–722. 
17.   Ebers, G.C.; Sadovnick, A.D. The geographic distribution of multiple sclerosis: A review. 
Neuroepidemiology 1993, 12, 1–5. 
18.   Ascherio, A.; Munger, K.L.; Simon, K.C. Vitamin D and multiple sclerosis. Lancet Neurol. 2010, 
9, 599–612. 
19.   Gale, C.R.; Martyn, C.N. Migrant studies in multiple sclerosis. Prog. Neurobiol. 1995,  47,  
425–448. 
20.   Pierrot-Deseilligny, C.; Souberbielle, J.C. Is hypovitaminosis D one of the environmental risk 
factors for multiple sclerosis? Brain 2010, 133, 1869–1888. 
21.    Lucas, R.M.; Ponsonby, A.L.; Dear, K.; Valery, P.C.; Pender, M.P.; Taylor, B.V.;   
Kilpatrick, T.J.; Dwyer, T.; Coulthard, A.; Chapman, C.; et al. Sun exposure and vitamin D are 
independent risk factors for CNS demyelination. Neurology 2011, 76, 540–548. 
22.   Davis, G.E., Jr.; Lowell, W.E. Solar cycles and their relationship to human disease and 
adaptability. Med. Hypotheses 2006, 67, 447–461. 
23.   Lowell, W.E.; Davis, G.E., Jr. The light of life: Evidence that the sun modulates human lifespan. 
Med. Hypotheses 2008, 70, 501–507. 
24.   Sunlight, Ultraviolet Radiation, and the Skin. NIH Consens Statement Online 1989, 7, 1–29. 
25.  Shindell, D.; Rind, D.; Balachandran, N.; Lean, J.; Lonergan, P. Solar cycle variability, ozone, 
and climate. Science 1999, 284, 305–308. 
26.  Feng, D.; Liu, T.; Sun, Z.; Bugge, A.; Mullican, S.E.; Alenghat, T.; Liu, X.S.; Lazar, M.A.  
A circadian rhythm orchestrated by histone deacetylase 3 controls hepatic lipid metabolism. 
Science 2011, 331, 1315–1319. 
27.   Elwood, J.M.; Jopson, J. Melanoma and sun exposure: an overview of published studies.   
Int. J. Cancer 1997, 73, 198–203. 
28.   Bronnum-Hansen, H.; Stenager, E.; Koch-Henriksen, N. The danish multiple sclerosis register. 
Scand. J. Pub. Health 2011, 39, 62–64. 
29.  Koch-Henriksen, N. The danish multiple sclerosis registry: A 50-year follow-up. Mult. Scler. 
1999, 5, 293–296. 
30.   Danmarks Statistik. Available online: www.statistikbanken.dk (accessed in January 2011). 
31.   Bentzen, J.; Flachs, E.M.; Stenager, E.; Bronnum-Hansen, H.; Koch-Henriksen, N. Prevalence of 
multiple sclerosis in Denmark 1950–2005. Mult. Scler. 2010, 16, 520–525. 
32.  National Oceanic and Atmospheric Administration. Available online: http://www.noaa.gov 
(accessed in January 2011). Int. J. Environ. Res. Public Health 2012, 9  697 
 
 
33.   Fernandes de Abreu, D.A.; Babron, M.C.; Rebeix, I.; Fontenille, C.; Yaouanq, J.; Brassat, D.; 
Fontaine, B.; Clerget-Darpoux, F.; Jehan, F.; Feron, F. Season of birth and not vitamin D receptor 
promoter polymorphisms is a risk factor for multiple sclerosis. Mult. Scler. 2009, 15, 1146–1152. 
34.   Baranzini, S.E.; Mudge, J.; van Velkinburgh, J.C.; Khankhanian, P.; Khrebtukova, I.; Miller, N.A.; 
Zhang, L.; Farmer, A.D.; Bell, C.J.; Kim, R.W.; et al. Genome, epigenome and RNA sequences 
of monozygotic twins discordant for multiple sclerosis. Nature 2010, 464, 1351–1356. 
35.   Yague, J.G.; Garcia-Segura, L.M.; Azcoitia, I. Selective transcriptional regulation of aromatase 
gene by vitamin D, dexamethasone, and mifepristone in human glioma cells. Endocrine 2009, 35, 
252–261. 
36.   Krishnan, A.V.; Swami, S.; Peng, L.; Wang, J.; Moreno, J.; Feldman, D. Tissue-selective 
regulation of aromatase expression by calcitriol: Implications for breast cancer therapy. 
Endocrinology 2010, 151, 32–42. 
37.   Barrera, D.; Avila, E.; Hernandez, G.; Halhali, A.; Biruete, B.; Larrea, F.; Diaz, L. Estradiol and 
progesterone synthesis in human placenta is stimulated by calcitriol. J. Steroid Biochem. Mol. Biol. 
2007, 103, 529–532. 
38.  Bronnum-Hansen, H.; Koch-Henriksen, N.; Stenager, E. Trends in survival and cause of death in 
Danish patients with multiple sclerosis. Brain 2004, 127, 844–850. 
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 